These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 6400508)

  • 21. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunological mechanisms in the central nervous system].
    Cazzullo CL; Smeraldi E
    Minerva Med; 1972 Apr; 63(28):1419-28. PubMed ID: 4553860
    [No Abstract]   [Full Text] [Related]  

  • 23. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease.
    Butts BD; Houde C; Mehmet H
    Cell Death Differ; 2008 Jul; 15(7):1178-86. PubMed ID: 18483490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].
    Tourtellotte WW
    Rev Neurol (Paris); 1972 Nov; 127(5):497-504. PubMed ID: 4588993
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oligodendrocytes have a key role in the development of CNS function and in myelin related diseases].
    Anderson ES; Bjartmar C
    Lakartidningen; 2000 Jul; 97(28-29):3265-8. PubMed ID: 10997013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis and central nervous system demyelination.
    Pouly S; Antel JP
    J Autoimmun; 1999 Nov; 13(3):297-306. PubMed ID: 10550217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
    Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ; Rodriguez M
    Microsc Res Tech; 1995 Oct; 32(3):230-45. PubMed ID: 8527857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoimmunity and nervous diseases].
    Lehoczky T
    Munch Med Wochenschr; 1966 Aug; 108(31):1518-22 passim. PubMed ID: 4169913
    [No Abstract]   [Full Text] [Related]  

  • 36. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myelin antibodies].
    Aarli JA
    Tidsskr Nor Laegeforen; 1975 Sep; 95(26):1485-9. PubMed ID: 1179363
    [No Abstract]   [Full Text] [Related]  

  • 38. [The pathogenesis of multiple sclerosis. Cytotoxic antibodies against myelin sheath tissue in multiple sclerosis].
    Frick E; Stickl H
    Fortschr Med; 1976 Jun; 94(17):1019-24. PubMed ID: 964856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.
    Itoyama Y; Sternberger NH; Kies MW; Cohen SR; Richardson EP; Webster H
    Ann Neurol; 1980 Feb; 7(2):157-66. PubMed ID: 6154439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for CXCR2 and CXCL1 on glia in multiple sclerosis.
    Omari KM; John G; Lango R; Raine CS
    Glia; 2006 Jan; 53(1):24-31. PubMed ID: 16086366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.